Qatar Precision Health Institute

What Qatar Precision Health Institute does

Qatar Precision Health Institute (QPHI) is a government-backed, non-profit precision health research institute headquartered at the Qatar Science and Technology Park in Doha, operating under Qatar Foundation. Formally established in 2024, it consolidates more than 12 years of work by the Qatar Biobank (est. 2012) and the Qatar Genome Program (2015) into a single platform that recruits Qatari population participants — nearly 50,000 to date — to contribute biological samples and phenotypic data, and returns personalized wellness, lifestyle, and clinically actionable genomic findings to consenting participants. Its core technical stack spans whole genome sequencing, transcriptomics, and epigenomics, supported by proprietary population-specific genotyping tools: Q-Chip and Q-Scan (for Qatari/regional variants and reproductive screening) and the Pan Arab Array (for 22 Arab countries), all built on its in-house QGP reference panel. The Disease Genomics Database institutionalizes WGS and multi-omics data sharing with national research partners.

QPHI's commercial posture is that of a research institute rather than a revenue-generating business. Revenue mechanics are dominated by Qatar Foundation allocations and QRDI Council grant funding (notably the Pathway Towards Precision Medicine program launched in 2015, funding 23+ research projects), supplemented by research services and regulated data access via institutional agreements. Customer segments are: (1) Qatari population participants (long-tail, contributing samples and receiving wellness reports covering 29 traits); (2) academic and medical researchers accessing the Research Portal and DGD; (3) healthcare professionals receiving pharmacogenomics training and tools (via QPGx-CARES); and (4) K-12/university students and the public via education programs (Genome Heroes app, DNA Museum, MOEHE schools program, EGC with Qatar University, PPCR with Harvard). Distribution is multi-modal: dedicated Research and Participant portals, healthcare provider network partnerships (HMC, Sidra, WCM-Q), regional distribution of genotyping arrays through Thermo Fisher, and a Microsoft/Azure-hosted infrastructure stack.

The institute operates as both a national precision medicine platform and a regional genomics infrastructure provider, with its competitive position anchored in the largest Arab-population genomic dataset globally and deep institutional integration across Qatar's healthcare, research, and education ecosystems. Expansion vectors — Tanawwo (Q4 2024), Pan Arab Array, QPGx-CARES, DGD — point toward a strategy of moving from biobanking infrastructure to translational and clinical genomics products, with potential future commercialization of population-specific genomics tools and consumer-facing reports.

Name

Qatar Precision Health Institute

Legal name

Qatar Precision Health Institute

Website

https://qphi.org.qa

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Qatar Precision Health Institute (QPHI) is a Qatar Foundation-backed, non-profit research institute in Doha that runs the national precision health genomics program — recruiting Qatari participants, building the largest Arab-population genomic dataset, and developing population-specific genotyping tools and clinical genomics services for researchers, healthcare providers, and the public.

Ownership category

akta.pro rank

Product category

Precision Health & Genomics Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Population Genomics & Preventive Precision Health Programs (HLAAANAL)

akta.pro secondary industries

Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Genomics research
• Precision medicine
• Whole genome sequencing
• Biobank services
• Population health

Headquarters

HQ city

Doha

HQ country

Qatar

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Government Research Funding: QPHI is funded primarily through Qatar Foundation and government allocations for precision medicine research initiatives, including grants for genomic research programs
2. Research Services and Data Access: Provides genomic data access and research services to qualified researchers through institutional agreements and data access requests

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

QPHI is a population-based precision health research institute that recruits Qatari participants, collects biological samples and health data, and conducts whole genome sequencing and multi-omics research. It delivers population-specific genotyping tools (Q-Chip, Q-Scan, Pan Arab Array), regulated genomic databases, personalized wellness and pharmacogenomics reports, and research data access through dedicated portals.

Product overview

QPHI is a population-based precision health research institute representing over 12 years of innovation building on Qatar Biobank and Qatar Genome Program. The core product portfolio centers on population-scale genomics infrastructure: Q-Chip (custom genotyping microarray), Disease Genomics Database (institutional data sharing platform), Q-Scan (reproductive genetic screening), Wellness and Lifestyle Genomic Reports (29-trait participant reports), QPGx-CARES (pharmacogenomics framework), Pan Arab Array (regional genotyping array), and the Return of Clinically Actionable Genomic Findings program. Supporting platforms include the Research Portal and Participant Portal for data access. Educational offerings encompass Genome Heroes mobile game/app, DNA Museum, PPCR training programs, Tanawwo networking platform, MOEHE Schools outreach, and Empower Generations Consortium partnerships with Qatar University. The PPM grant program funds collaborative genomic research across Qatar institutions.

Differentiator

Problem solved

Functional benefit

Brands

• Qatar Biobank (QBB): Biobank initiative for collecting biological samples and health/lifestyle data from Qatari population
• Qatar Genome Program (QGP)
• Q-Chip
• Wellness and Lifestyle Initiative
• QPGx-CARES
• Tanawwo (تَنَوُّع)
• Q-Scan
• Genome Heroes
• Empower Generations Consortium (EGC)
• Genomics and Precision Medicine Program (GPM)
• Pathway Towards Precision Medicine (PPM)

Quantifiable outcome

• Nearly 50,000 participants recruited for precision health research
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

16 partnerships are on record, tiered major, core and support.

• Harvard T.H. Chan School of Public HealthmajorStrategic or Co-development Partner · 1 January 2026QPHI is host site support center for Principles and Practice of Clinical Research (PPCR) distance-learning program, providing certification in clinical research methodology.
• Msheireb MuseumsmajorStrategic or Co-development Partner · 1 January 2017Collaboration to create DNA permanent exhibition 'Journey to the Heart of Life' at Bin Jelmood House. Includes workshops for children and families on genome science.
• Qatar Research, Development and Innovation (QRDI) CouncilcoreStrategic or Co-development Partner · 1 January 2015Annual grant scheme 'Pathway Towards Precision Medicine' (PPM) launched in 2015 to support local researchers working on genomics and precision medicine. PPM continues as flagship grant program for directing genomic research in Qatar.
• Weill Cornell Medicine-QatarcoreStrategic or Co-development PartnerPartnership with Department of Genetic Medicine to facilitate development of Q-Chip, Qatar's first gene chip for translating genomic research into clinical care specific to Qatari population.
• Hamad Medical Corporation (Diagnostic Genomic Division)coreStrategic or Co-development PartnerCollaboration on Q-Chip development as part of national efforts to translate genomic research into clinical applications.
• Sidra MedicinecoreStrategic or Co-development PartnerSidra research team partnership in Q-Chip development and multiple research consortium initiatives.
• Qatar UniversitycoreStrategic or Co-development PartnerJoint collaboration under Empower Generations Consortium (EGC) to exchange knowledge and expertise in life sciences education. Also partners on Genomics and Precision Medicine Program (GPM).
• Ministry of Education and Higher Education (MOEHE)majorStrategic or Co-development PartnerCollaboration on genomics education workshops for primary science teachers (grades 4-6) and biology teachers (grades 7-12), focusing on fundamentals of genomics and teaching strategies.
• Qatar Foundation's Pre-University Education (PUE)majorStrategic or Co-development PartnerOngoing strategic collaboration launching educational workshops and activations for primary school students in genome science through interactive learning methods.
• International Agency for Research on Cancer / World Health Organization (IARC/WHO)majorStrategic or Co-development PartnerPartnership for workshop on biobanking and predictive genomics to empower countries' science and policy leaders to establish national genomics initiatives.
• Thermo Fisher ScientificmajorStrategic or Co-development PartnerPartner in workshop on biobanking and predictive genomics, also manufacturing partner for Pan Arab Array custom design.
• MEEZAsupportTechnology or IntegrationData center partnership for hosting the Participants Relationship Management Portal.
• MicrosoftsupportTechnology or IntegrationWeb portal hosted on Microsoft Azure subscription; Microsoft CRM used to store participant information and reservations.
• GooglesupportTechnology or IntegrationGoogle Analytics employed to analyze website activities including hits, visited pages, and geographic sources.
• GitLabsupportTechnology or IntegrationSelf-hosted instance of GitLab utilized for developer tools.
• DrupalsupportTechnology or IntegrationContent management system used for the QPHI website.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Helix: Population genomics company operating a DNA sequencing platform-as-a-service model serving health systems, health plans, and consumer brands. Comparable to QPHI's translational genomics and population-scale sequencing infrastructure, though commercially focused.
• 23andMe: Direct-to-consumer genetic testing company offering genotyping reports on health, ancestry, and traits. Comparable to QPHI's Wellness and Lifestyle Genomic Reports in delivering population-facing genomic reports, though DTC model and ancestry focus differ.

Direct peers

• deCODE Genetics: Iceland-based population genomics company (acquired by Amgen) that built its entire business on population-specific whole genome sequencing at national scale. Most directly comparable to QPHI's model of leveraging a small, genetically homogeneous population for variant discovery and precision medicine.
• GenomeAsia 100K: Non-profit consortium sequencing 100,000 Asian genomes to enable population-specific medical research. Highly comparable to QPHI's mission of building population-specific genomic reference panels for underrepresented populations, sharing similar positioning between regional and global genomics ecosystems.

Broad incumbents

• Genomics England: UK government-backed genomics program running the 100,000 Genomes Project and the NHS Genomic Medicine Service. Highly comparable to QPHI as a national population genomics initiative combining biobanking, whole genome sequencing, clinical translation, and government funding—though at significantly larger scale.
• UK Biobank: Large-scale biomedical database with 500,000+ UK participants linked to health records, including genetic data. Highly comparable to Qatar Biobank's biobanking and population-scale genomic research model, though UK Biobank serves a global research community.
• Regeneron Genetics Center: Industry-leading genomics program sequencing exomes/genomes of millions of participants tied to electronic health records for drug discovery. Comparable in large-scale genomic data generation and pharmaceutical utility, though commercially driven versus QPHI's government/research mission.
• NIH All of Us Research Program: US National Institutes of Health precision medicine initiative targeting 1 million+ participants with rich genomic and phenotypic data. Comparable in government-funded population-scale genomics and biobanking mission, though at vastly larger scale and budget.

Regional players

• Saudi Human Genome Program: Saudi Arabia's national precision medicine initiative sequencing 100,000 Saudi genomes. A direct regional competitor to QPHI with a larger population base and similar focus on Arab population genomics—would compete for regional grants, talent, and Pan Arab Array adoption.
• Emirati Genome Program: UAE national program sequencing Emirati genomes to enable precision medicine in the UAE. Direct regional peer to QPHI in scope, funding model (government-backed), and Arab population focus—operating in adjacent GCC territory.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/_QPHI
• YouTubeyoutube.com/@_qphi
• Facebookfacebook.com/profile.php
• Instagraminstagram.com/qatarprecisionhealthinstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qatar Precision Health Institute